Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Current Leases came in at $428000.0 in Q1 2026, up 34.17% year-on-year from $319000.0 in Q1 2025, and up 6.2% quarter-over-quarter from $403000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Current Leases (2019 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $428000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 34.17% year-over-year to $428000.0 in Q1 2026; TTM through Mar 2026 was $428000.0, a 34.17% increase from a year earlier, with the FY2025 full-year figure at $403000.0, up 117.84% from the prior year.
- Current Leases improved to $428000.0 in Q1 2026 per CRVS's latest filing, from $403000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.4 million in Q4 2023 and bottomed at $185000.0 in Q4 2024.
- The 5-year median for Current Leases is $1.0 million (2024), against an average of $827588.2.
- Across the five-year window, Current Leases tumbled 86.54% in 2024 and jumped 117.84% in 2025, its largest moves.
- Year by year, Current Leases stood at $1.2 million in 2022, then grew by 11.89% to $1.4 million in 2023, then tumbled by 86.54% to $185000.0 in 2024, then soared by 117.84% to $403000.0 in 2025, then rose by 6.2% to $428000.0 in 2026.
- Per Business Quant, the three latest CRVS Current Leases figures stand at $428000.0 (Q1 2026), $403000.0 (Q4 2025), and $379000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | 428,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428,000.00 |
| Dec 31, 2025 | 403,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 355,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.09 Mn |
| Dec 31, 2021 | 1.05 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.15 Mn |